Search Results

Study focuses on Hippo signaling pathway as critical link between fibrosis, vascular dysfunction, and sex bias in systemic sclerosis

About 85% of Multiple Sclerosis cases are diagnosed and treated in people between 18 & 50 years of age, and little has been published regarding those outside of this age grou

Examining Medication Efficacy in MS Treatment- Insights Across Diverse Racial and Ethnic Groups

Wistar’s Lieberman lab show that EBV-infected B cells contribute to multiple sclerosis (MS) inflammation and can be selectively targeted to reduce MS autoimmune response

UCSF scientists clear a potential path toward earlier treatment for multiple sclerosis that affects nearly 1,000,000 people in the United States

Scientists have discovered a harbinger in the blood of some people who later went on to develop multiple sclerosis.